WarrenWWasiewskiMD
Child Neurology • Hershey, PAHead of Research and Development and Chief Medical Officer for BioBlast Pharma
Dr. Wasiewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
Hershey, PA 17033Phone+1 800-243-1455
Education & Training
Baylor College of MedicineFellowship, Child Neurology, 1986 - 1987- Baylor College of MedicineResidency, Neurology, 1984 - 1986
University at BuffaloResidency, Pediatrics, 1982 - 1984- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1982
Certifications & Licensure
PA State Medical License 1987 - 2024- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Start of enrollment: 2005 Sep 01
- ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Start of enrollment: 2006 Mar 01
- Compassionate Use of Stannsoporfin in Addition to Phototherapy to Reduce the Need for Exchange Transfusions in Term and Near-Term Infants Start of enrollment: 2003 Oct 01
Publications & Presentations
PubMed
- 36 citationsChallenges and opportunities in designing clinical trials for neuromyelitis opticaBrian G. Weinshenker, Gerard Barron, Jacinta M. Behne, Jeffery L. Bennett, Peter Chin
Neurology. 2015-04-28 - 17 citationsAncrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies.David E. Levy, James Trammel, Warren W. Wasiewski
Journal of Stroke and Cerebrovascular Diseases. 2009-01-01 - 62 citationsAncrod in acute ischemic stroke: Results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke programDavid E. Levy, Gregory J. del Zoppo, Bart M. Demaerschalk, Andrew M. Demchuk, Hans-Christoph Diener
Stroke. 2009-12-01
Press Mentions
Bio Blast Pharma Explodes on Positive ResultsMarch 16th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
